Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine

Psychopharmacology

Volumn 158, Issue 3, 2001, Pages 273-280

  Wang, Guanghui ^a   Fowler, Stephen C ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Force plate; Fourier analysis; Harmaline; Locomotor activity; Physostigmine; Rat; Tremor

Indexed keywords

HARMALINE; PHYSOSTIGMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; FOURIER ANALYSIS; INFERIOR OLIVE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREMOR;

ANIMALS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; HARMALINE; MALE; MOTOR ACTIVITY; PHYSOSTIGMINE; RATS; RATS, SPRAGUE-DAWLEY; TREMOR;

EID: 0035165960     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100882     Document Type: Article

References (44)

1. Psychomotor functions in developing rats: Ontogenetic approach to structure-function relationships
2. Olivo-cerebellar activity during harmaline-induced tremor. A 2-[14C]deoxyglucose study
3. Harma-line-induced tremor. I. Regional metabolic activity as revealed by [14C]2-deoxyglucose in cat
4. The effects of DL Dopa on harmaline induced tremor and on resting tremor in monkeys with tegmental lesions
5. Effect of harmaline in monkeys with central nervous system lesions
6. Comparison of intracisternally and intraperito-neally injected harmaline on body temperature and tremor in the rat
7. The pathophysiology of essential tremor
8. Differential attenuation by atropine and d-amphetamine on hyperactivity: Possible clinical implications
9. Validation of a pho-tobeam system for assessment of motor activity in rats
10. A force-plate actometer for quantitating rodent behaviors: Illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor
11. Tremor in the monkey with a cerebellar lesion
12. Ethanol withdrawal tremor does not interact with physostigmine-induced tremor in rat
13. Drugs for Parkinson's disease reduce tremor induced by physostigmine
14. 3-Acetylpyridine: A tool to inhibit the tremor and the increase of cGMP content in cerebellar cortex elicited by harmaline
15. Neurophysiological and behavioral maturation of cerebellar function studied with tremoro-genic drugs
16. Analysis of local cholin-ergic tremor mechanisms following selective neurochemical lesions
17. Tremorgenic mechanisms in primates
18. Neurophysiological studies of harmaline-induced tremor in the cat
19. Harmaline-induced rhythmic activity of alpha and gamma motoneurons in the cat
20. Harma-line-induced rhythmic activity of cerebellar and lower brain stem neurons
21. Central mechanisms of tremor in some feline and primate models
22. Toxicity study of continuous administration of physostigmine salicylate
23. The olivo-cerebellar system: Functional properties as revealed by harmaline-induced tremor
24. Decreased cerebellar 3′,5′-cyclic guanosine mon0phosphate levels and insensitivity to harmaline in the genetically dyston-ic rat (dt)
25. Purkinje cell activity in rats following chronic treatment with harma-line
26. Tolerance to the tremorogenic effects of harmaline: Evidence for altered olivo-cerebellar function
27. On the interaction of drugs with the cholinergic nervous system. V. Characterization of some effects induced by physostigmine in mice: In vivo and in vitro studies
28. EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive
29. Rhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the cat
30. Cholinesterase inhibitors in the treatment of Alzheimer's disease: A comparison of tolerability and pharmacology
31. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline
32. Ontogeny of behavioral arousal in rats: Effect of maternal and sibling presence
33. Neurobehavioral toxicity of 2,4-D-n-butyl ester (2,4-D ester): Tolerance and lack of cross-tolerance
34. Antimuscarinic drugs-effect on brain acetylcholine and tremors in rats
35. Quantitative analysis of drug-induced tremor in mice
36. Further studies on quantification of drug-induced tremor in mice: Effects of antitrem-orogenic agents on tremor frequency
37. The effectiveness of different isomers of octanol as blockers of harma-line-induced tremor
38. The effects of triethylcholine and hem-icholinium-3 on tremor and brain acetylcholine
39. Scopolamine reversal of tremor produced by low doses of physostigmine in rats: Evidence for a cholinergic mechanism
40. At low doses, harmaline increases forelimb tremor in the rat
41. Effect of harmaline on cells of the inferior olive in the absence of tremor: Differential response of genetically dystonic and harmaline-tolerant rats
42. Systemic harmaline blocks associative and motor learning by the actions of the inferior olive
43. Removal of the inferior olive abolishes myoclonic seizures associated with a loss of olivary serotonin
44. Significance of central noradrenergic system on harmaline induced tremor